Evidence map›Paper›PMID 24803715›Full record

ArticleBulletin epidemiologique hebdomadaire (Paris, France)2013

Evaluation of the smoking ban in public places in France one year and five years after its implementation: Findings from the ITC France survey.

Geoffrey T Fong, Lorraine V Craig, Romain Guignard, Gera E Nagelhout, Megan K Tait, Pete Driezen, Ryan David Kennedy, Christian Boudreau, Jean-Louis Wilquin, Antoine Deutsch and 1 more

Abstract read
In one paragraph

Article in Bulletin epidemiologique hebdomadaire (Paris, France), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Commentary on the Culture of Prevention.Prevention science : the official journal of the Society for Prevention Research · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Geoffrey T FongDepartment of Psychology, University of Waterloo, Waterloo, Ontario, Canada ; School of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada ; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Lorraine V CraigDepartment of Psychology, University of Waterloo, Waterloo, Ontario, Canada.
Romain GuignardInstitut national de prévention et d'éducation pour la santé (Inpes), Saint-Denis, France.
Gera E NagelhoutMaastricht University, School for Public Health and Primary Care (CAPHRI), Maastricht, Pays-Bas ; STIVORO Dutch Expert Centre on Tobacco Control, La Haye, Pays-Bas.
Megan K TaitDepartment of Psychology, University of Waterloo, Waterloo, Ontario, Canada.
Pete DriezenPropel Centre for Population Health Impact, University of Waterloo, Waterloo, Ontario, Canada.
Ryan David KennedyPropel Centre for Population Health Impact, University of Waterloo, Waterloo, Ontario, Canada ; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, États-Unis.
Christian BoudreauDepartment of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.
Jean-Louis WilquinInstitut national de prévention et d'éducation pour la santé (Inpes), Saint-Denis, France.
Antoine DeutschInstitut national du cancer (INCa), Boulogne-Billancourt, France.
François BeckInstitut national de prévention et d'éducation pour la santé (Inpes), Saint-Denis, France ; Cermes3-Équipe Cesames (Centre de recherche Médecine, sciences, santé, santé mentale, société), Université Paris Descartes, Sorbonne Paris Cité/CNRS UMR 8211/Inserm U988/EHESS, Paris, France.

Funding

Variation in Cigarettes, Tobacco use Behaviors and Exposures in ITC CountriesP01CA138389 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI THOMPSON, MARY · 2009 to 2013
$13.4M
NCI NIH HHS P01 CA138389
6 · The paper itself

Abstract

France implemented a comprehensive smoke-free policy in public places in February 2007 for workplaces, shopping centres, airports, train stations, hospitals and schools. On January 2008, it was extended to meeting places (bars, restaurants, hotels, casinos, nightclubs). This paper evaluates France's smoke-free law based on the International Tobacco Control Policy Evaluation Project in France (the ITC France Project), which conducted a cohort survey of approximately 1,500 smokers and 500 non-smokers before the implementation of the laws (Wave 1, conducted December 2006 to February 2007) and two waves after the implementation (Wave 2, conducted between September-November 2008; and Wave 3, conducted between September-December 2012). Results show that the smoke-free law led to a very significant and near total elimination of indoor smoking in key venues such as bars (from 95.9% to 3.7%) and restaurants (from 64.7% to 2.3%) at Wave 2, which was sustained four years later at Wave 3 (1.4% in restaurants; 6.6% in bars). Smoking in workplaces declined significantly after the law (from 42.6% to 19.3%), which continued to decline at Wave 3 (to 12.8%). Support for the smoke-free law increased significantly after their implementation and continued to increase at Wave 3 (among smokers for bars and restaurants; among smokers and non-smokers for workplaces). The findings demonstrate that smoke-free policies that are implemented in ways consistent with the Guidelines for Article 8 of the WHO Framework Convention on Tobacco Control (WHO FCTC) lead to substantial and sustained reductions in tobacco smoke in public places while also leading to high levels of support by the public.

Indexed as

evaluation of public policiesmeeting placesecond-hand smokesmoking banTobaccoworkplace

Identifiers

PMID24803715
PMCPMC4009376

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.